市場調査レポート

商品コード

1303775

持続血糖モニタリングシステム市場：製品、コンポーネント、検査部位、患者ケア環境、用途別-2023～2030年の世界予測

Continuous Blood Glucose Monitoring Systems Market by Product, Component, Testing Site, Patient Care Setting, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

持続血糖モニタリングシステムの世界市場は、2023年にCAGR 8.12%で45億469万米ドルと予測され、2030年には77億9,404万米ドルと驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の持続血糖モニタリングシステム市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.持続血糖モニタリングシステムの世界市場規模および予測は？

2.予測期間中、世界の持続血糖モニタリングシステム市場を形成するCOVID-19の阻害要因と影響は？

3.持続血糖モニタリングシステムの世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.持続血糖モニタリングシステムの世界市場における競争戦略は？

5.持続血糖モニタリングシステムの世界市場における技術動向と規制の枠組みは？

6.持続血糖モニタリングシステムの世界市場における主要ベンダーの市場シェアは？

7.持続血糖モニタリングシステムの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 増加する糖尿病患者に対する血糖値の急激な変化を検出する効果的な方法が必要
  - ポイントオブケア血糖計よりも持続血糖モニタリングシステムに関連する利点
  - 製品に対する政府の取り組み別認知度の向上
- 抑制要因
  - 測定の精度と精度、およびセンサーの寿命に関連するコスト
- 機会
  - 在宅ヘルスケアにおける持続血糖モニタリングシステムの採用率の増加
  - 潜在的な未診断患者集団
- 課題
  - パターンの不安定性と結果の再現性
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章持続血糖モニタリングシステム市場：製品別

イントロダクション
継続的グルコースモニタリングシステム
- 受信機
- センサー
- 送信機
自己血糖測定システム
- 血糖測定器
- ランセットおよび穿刺装置
- テストストリップ

第7章持続血糖モニタリングシステム市場：コンポーネント別

イントロダクション
CGMモニター
CGM送信機
グルコースセンサー

第8章持続血糖モニタリングシステム市場：検査部位別

イントロダクション
代替サイトのテスト
指先検査

第9章持続血糖モニタリングシステム市場：患者ケア環境別

イントロダクション
病院とクリニック
セルフケアまたはホームケア

第10章持続血糖モニタリングシステム市場：用途別

イントロダクション
妊娠糖尿病
1型糖尿病
2型糖尿病

第11章南北アメリカの持続血糖モニタリングシステム市場

イントロダクション
アルゼンチン
ブラジル
カナダ
メキシコ
米国

第12章アジア太平洋地域の持続血糖モニタリングシステム市場

イントロダクション
オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第13章欧州・中東・アフリカの持続血糖モニタリングシステム市場

イントロダクション
デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第14章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第15章掲載企業一覧

第16章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2022 VS 2030
FIGURE 3. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 5. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
FIGURE 6. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2022 VS 2030 (%)
FIGURE 7. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2022 VS 2030 (%)
FIGURE 8. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 9. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 10. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET DYNAMICS
FIGURE 11. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 21. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 5. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 6. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 11. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY BLOOD GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LANCETS & LANCING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 16. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM MONITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM TRANSMITTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GLUCOSE SENSOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 20. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ALTERNATE SITE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY FINGERTIP TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 23. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF OR HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 53. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 54. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 55. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 56. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 57. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 90. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 91. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 92. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 93. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 94. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 97. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 98. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 99. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 100. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 101. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 111. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 112. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 113. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 114. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 115. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 125. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 132. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 139. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 140. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 147. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 153. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 154. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 155. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 156. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 157. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 160. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 161. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 175. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 176. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 177. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 178. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 179. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 182. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 183. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 184. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 185. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 186. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 189. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 190. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 191. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 193. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 196. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 197. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 198. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 199. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 200. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 203. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 204. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 205. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 206. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 207. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 217. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 218. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 219. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 220. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 221. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 237. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 238. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 239. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 240. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 241. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 245. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 246. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 247. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 248. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 249. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 252. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 253. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 254. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 255. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 256. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE

Product Code: MRR-433AB1DC2936

The Global Continuous Blood Glucose Monitoring Systems Market is forecasted to grow significantly, with a projected USD 4,504.69 million in 2023 at a CAGR of 8.12% and expected to reach a staggering USD 7,794.04 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Continuous Blood Glucose Monitoring Systems Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Continuous Blood Glucose Monitoring Systems Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Continuous Glucose Monitoring Systems and Self-Monitoring Blood Glucose Systems. The Continuous Glucose Monitoring Systems is further studied across Receivers, Sensors, and Transmitters. The Self-Monitoring Blood Glucose Systems is further studied across Blood Glucose Meters, Lancets & Lancing Devices, and Testing strips. The Self-Monitoring Blood Glucose Systems is projected to witness significant market share during forecast period.

Based on Component, market is studied across CGM Monitor, CGM Transmitter, and Glucose Sensor. The Glucose Sensor is projected to witness significant market share during forecast period.

Based on Testing Site, market is studied across Alternate Site Testing and Fingertip Testing. The Fingertip Testing is projected to witness significant market share during forecast period.

Based on Patient Care Setting, market is studied across Hospital & Clinics and Self or Home Care. The Self or Home Care is projected to witness significant market share during forecast period.

Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes. The Type 2 Diabetes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Continuous Blood Glucose Monitoring Systems Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Continuous Blood Glucose Monitoring Systems Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Blood Glucose Monitoring Systems Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Blood Glucose Monitoring Systems Market?

4. What is the competitive strategic window for opportunities in the Global Continuous Blood Glucose Monitoring Systems Market?

5. What are the technology trends and regulatory frameworks in the Global Continuous Blood Glucose Monitoring Systems Market?

6. What is the market share of the leading vendors in the Global Continuous Blood Glucose Monitoring Systems Market?

7. What modes and strategic moves are considered suitable for entering the Global Continuous Blood Glucose Monitoring Systems Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Continuous Blood Glucose Monitoring Systems Market, by Product, 2022 vs 2030
4.3. Continuous Blood Glucose Monitoring Systems Market, by Component, 2022 vs 2030
4.4. Continuous Blood Glucose Monitoring Systems Market, by Testing Site, 2022 vs 2030
4.5. Continuous Blood Glucose Monitoring Systems Market, by Patient Care Setting, 2022 vs 2030
4.6. Continuous Blood Glucose Monitoring Systems Market, by Application, 2022 vs 2030
4.7. Continuous Blood Glucose Monitoring Systems Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
  - 5.1.1.2. Benefits associated with continuous blood glucose monitoring systems over Point-of-Care glucometers
  - 5.1.1.3. Increasing awareness through government initiatives for the product
- 5.1.2. Restraints
  - 5.1.2.1. Accuracy and precision on measurement and cost associated with sensor lifetime
- 5.1.3. Opportunities
  - 5.1.3.1. Growing adoption rate of continuous blood glucose monitoring systems in home healthcare
  - 5.1.3.2. Potential undiagnosed patient population
- 5.1.4. Challenges
  - 5.1.4.1. Instability of patterns and reproducibility to results
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Continuous Blood Glucose Monitoring Systems Market, by Product

6.1. Introduction
6.2. Continuous Glucose Monitoring Systems
- 6.2.1. Receivers
- 6.2.2. Sensors
- 6.2.3. Transmitters
6.3. Self-Monitoring Blood Glucose Systems
- 6.3.1. Blood Glucose Meters
- 6.3.2. Lancets & Lancing Devices
- 6.3.3. Testing strips

7. Continuous Blood Glucose Monitoring Systems Market, by Component

7.1. Introduction
7.2. CGM Monitor
7.3. CGM Transmitter
7.4. Glucose Sensor

8. Continuous Blood Glucose Monitoring Systems Market, by Testing Site

8.1. Introduction
8.2. Alternate Site Testing
8.3. Fingertip Testing

9. Continuous Blood Glucose Monitoring Systems Market, by Patient Care Setting

9.1. Introduction
9.2. Hospital & Clinics
9.3. Self or Home Care

10. Continuous Blood Glucose Monitoring Systems Market, by Application

10.1. Introduction
10.2. Gestational Diabetes
10.3. Type 1 Diabetes
10.4. Type 2 Diabetes

11. Americas Continuous Blood Glucose Monitoring Systems Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Continuous Blood Glucose Monitoring Systems Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

持続血糖モニタリングシステム市場：製品、コンポーネント、検査部位、患者ケア環境、用途別-2023～2030年の世界予測

Continuous Blood Glucose Monitoring Systems Market by Product, Component, Testing Site, Patient Care Setting, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 持続血糖モニタリングシステム市場：製品別

第7章 持続血糖モニタリングシステム市場：コンポーネント別

第8章 持続血糖モニタリングシステム市場：検査部位別

第9章 持続血糖モニタリングシステム市場：患者ケア環境別

第10章 持続血糖モニタリングシステム市場：用途別

第11章 南北アメリカの持続血糖モニタリングシステム市場

第12章 アジア太平洋地域の持続血糖モニタリングシステム市場

第13章 欧州・中東・アフリカの持続血糖モニタリングシステム市場

第14章 競合情勢

第15章 掲載企業一覧

第16章 付録